Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity. Zhang H, Sabiu G, Jung S, Podesta MA, et al. Kidney Int 2025;108:48-56.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang H, Sabiu G, Jung S, Podesta MA, et al. Targeted delivery of IL-21 neutralizing nanotherapeutics to lymph nodes and kidney allografts attenuates B cell alloimmunity. Kidney Int 2025;108:48-56.
PMID: 40268164